Biofourmis is a Singapore-born digital-health company whose AI analyzes patient biosignals to predict deterioration and power at-home care.
Biofourmis builds machine-learning models that learn from continuous physiological data — heart rate, ECG, activity — to spot early signs of deterioration, and pairs them with a virtual-care platform used by hospitals and pharma. Its technology supports hospital-at-home programs, decentralized clinical trials and chronic-disease management, with FDA-cleared analytics in its portfolio. The company grew from a Singapore spin-out to a global digital therapeutics player.
Biofourmis works with healthcare organizations under enterprise agreements and partnership programs; pricing is scoped per deployment.
Hospital systems, pharma companies and payers running virtual care, remote monitoring and digital-therapeutic programs.
Biofourmis supports care programs that move beyond the hospital walls.
Health organizations partner with Biofourmis to design programs, deploy devices and integrate data with clinical systems.
Earlier clinical intervention, reduced readmissions and trial data collection that doesn’t depend on clinic visits.
Programs are co-designed: patient selection, device logistics, model configuration and clinical-system integration all happen with Biofourmis’s team before monitoring begins.
Healthcare deployment demands regulatory diligence, workflow redesign and clinical ownership — this is a program, not an app.
Health systems value earlier intervention signals that keep patients safely at home.
Hospital-at-home programs, pharma trials and chronic-disease management initiatives.
Hospital-at-home only works if deterioration is caught early. Biofourmis combines validated prediction with the operational platform to act on it. Health systems ready to move care beyond walls will find a capable partner.
Biofourmis fits institutions moving care beyond hospital walls. Predictive analytics plus operational platform is exactly the combination those programs need.
No. Biofourmis is a healthcare platform delivered through institutional agreements and clinical programs.
Device and EHR integrations are supported through defined interfaces within customer deployments.
Against simple remote-monitoring tools, Biofourmis adds validated predictive analytics and complete care-program infrastructure.
Metabase is an open-source business intelligence tool that lets anyone in a company ask questions of their data without SQL. OverviewMetabase makes…
Databricks is a unified data and AI platform combining a lakehouse architecture with analytics, machine learning, and generative AI tooling. OverviewDatabricks provides…
WJX (问卷星) is a Chinese online survey and data collection platform covering questionnaires, exams, polls, and registration forms, with AI-assisted authoring and…
